JP2011527902A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527902A5 JP2011527902A5 JP2011518030A JP2011518030A JP2011527902A5 JP 2011527902 A5 JP2011527902 A5 JP 2011527902A5 JP 2011518030 A JP2011518030 A JP 2011518030A JP 2011518030 A JP2011518030 A JP 2011518030A JP 2011527902 A5 JP2011527902 A5 JP 2011527902A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antibody
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims 19
- 101100112922 Candida albicans CDR3 gene Proteins 0.000 claims 16
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 206010011831 Cytomegalovirus infection Diseases 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 210000002798 bone marrow cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000002889 endothelial cell Anatomy 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000002207 retinal effect Effects 0.000 claims 1
- 210000002536 stromal cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8133408P | 2008-07-16 | 2008-07-16 | |
| US61/081,334 | 2008-07-16 | ||
| PCT/IB2009/006641 WO2010007533A2 (en) | 2008-07-16 | 2009-07-15 | Human cytomegalovirus neutralizing antibodies and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013218791A Division JP5807050B2 (ja) | 2008-07-16 | 2013-10-22 | ヒトサイトメガロウイルス中和抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011527902A JP2011527902A (ja) | 2011-11-10 |
| JP2011527902A5 true JP2011527902A5 (enExample) | 2012-05-17 |
| JP5422649B2 JP5422649B2 (ja) | 2014-02-19 |
Family
ID=41550776
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518030A Expired - Fee Related JP5422649B2 (ja) | 2008-07-16 | 2009-07-15 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2013218791A Expired - Fee Related JP5807050B2 (ja) | 2008-07-16 | 2013-10-22 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2015082325A Expired - Fee Related JP6062477B2 (ja) | 2008-07-16 | 2015-04-14 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2016241815A Expired - Fee Related JP6345753B2 (ja) | 2008-07-16 | 2016-12-14 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2018098457A Expired - Fee Related JP6703037B2 (ja) | 2008-07-16 | 2018-05-23 | ヒトサイトメガロウイルス中和抗体およびその使用 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013218791A Expired - Fee Related JP5807050B2 (ja) | 2008-07-16 | 2013-10-22 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2015082325A Expired - Fee Related JP6062477B2 (ja) | 2008-07-16 | 2015-04-14 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2016241815A Expired - Fee Related JP6345753B2 (ja) | 2008-07-16 | 2016-12-14 | ヒトサイトメガロウイルス中和抗体およびその使用 |
| JP2018098457A Expired - Fee Related JP6703037B2 (ja) | 2008-07-16 | 2018-05-23 | ヒトサイトメガロウイルス中和抗体およびその使用 |
Country Status (30)
| Country | Link |
|---|---|
| US (21) | US8124093B2 (enExample) |
| EP (3) | EP3178845A1 (enExample) |
| JP (5) | JP5422649B2 (enExample) |
| KR (1) | KR101356350B1 (enExample) |
| CN (3) | CN103980363B (enExample) |
| AU (1) | AU2009272284C1 (enExample) |
| BR (1) | BRPI0916443A2 (enExample) |
| CA (2) | CA2730776C (enExample) |
| CL (3) | CL2011000084A1 (enExample) |
| CO (1) | CO6351801A2 (enExample) |
| CR (2) | CR20160355A (enExample) |
| CU (1) | CU23953B1 (enExample) |
| DK (2) | DK3009449T3 (enExample) |
| EA (1) | EA031177B1 (enExample) |
| EC (2) | ECSP11010826A (enExample) |
| ES (2) | ES2654543T3 (enExample) |
| GT (4) | GT201100011CA (enExample) |
| HN (1) | HN2011000161A (enExample) |
| IL (7) | IL210356A (enExample) |
| MA (1) | MA32561B1 (enExample) |
| MX (5) | MX343250B (enExample) |
| NZ (5) | NZ603499A (enExample) |
| PE (7) | PE20141432A1 (enExample) |
| PH (1) | PH12015500782A1 (enExample) |
| PL (2) | PL2352759T3 (enExample) |
| PT (2) | PT2352759T (enExample) |
| SG (3) | SG10201608381SA (enExample) |
| UA (1) | UA106354C2 (enExample) |
| WO (1) | WO2010007533A2 (enExample) |
| ZA (1) | ZA201600335B (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
| GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
| CA2730776C (en) | 2008-07-16 | 2018-12-11 | Institute For Research In Biomedicine | Human cytomegalovirus neutralizing antibodies and use thereof |
| SG181901A1 (en) | 2009-12-23 | 2012-08-30 | 4Antibody Ag | Binding members for human cytomegalovirus |
| WO2011159938A2 (en) | 2010-06-16 | 2011-12-22 | Trellis Bioscience, Inc. | High affinity human antibodies to human cytomegalovirus (cmv) gb protein |
| HUE026646T2 (en) | 2010-07-06 | 2016-07-28 | Glaxosmithkline Biologicals Sa | Preferred liposomes containing lipids of PKA value for delivery of RNA |
| SI3243526T1 (sl) | 2010-07-06 | 2020-02-28 | Glaxosmithkline Biologicals S.A. | Dostava RNA za sprožitev večih imunskih poti |
| PL2591114T3 (pl) | 2010-07-06 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Immunizacja dużych ssaków małymi dawkami rna |
| RS63329B1 (sr) | 2010-08-31 | 2022-07-29 | Glaxosmithkline Biologicals Sa | Pegilovani lipozomi za isporuku rnk koja kodira imunogen |
| US20120082666A1 (en) * | 2010-09-29 | 2012-04-05 | Xiaocheng Chen | Antibody compositions and methods of use |
| CN103269713B (zh) | 2010-10-11 | 2016-01-20 | 诺华有限公司 | 抗原递送平台 |
| EP3332802A1 (en) | 2011-07-06 | 2018-06-13 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
| JP2015518471A (ja) * | 2012-03-28 | 2015-07-02 | ジェネンテック， インコーポレイテッド | 抗ｈｃｍｖイディオタイプ抗体およびそれらの使用 |
| AU2013293570B2 (en) | 2012-07-27 | 2019-05-23 | City Of Hope | An MVA vaccine for delivery of a UL128 complex and preventing CMV infection |
| US10413620B2 (en) | 2012-08-17 | 2019-09-17 | The Regents Of The University Of Colorado, A Body Corporate | Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging |
| WO2014028865A1 (en) * | 2012-08-17 | 2014-02-20 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for detecting complement activation |
| KR101935088B1 (ko) | 2012-08-24 | 2019-01-04 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Ror1 암을 치료하고 전이를 저해하는데 이용을 위한 항체와 백신 |
| US20170296650A1 (en) | 2014-10-08 | 2017-10-19 | Novartis Ag | Combination of human cytomegalovirus neutralizing antibodies |
| EP3048114A1 (en) * | 2015-01-22 | 2016-07-27 | Novartis AG | Cytomegalovirus antigens and uses thereof |
| ES2899227T3 (es) | 2015-04-07 | 2022-03-10 | Alector Llc | Anticuerpos anti sortilina y métodos de uso de los mismos |
| EP3347045A4 (en) | 2015-09-10 | 2019-08-28 | City of Hope | MVA-GH / GL-PC VACCINATED ANTIBODIES FOR NEUTRALIZING THE INFECTIOSITY OF HUMAN CYTOMEGALOVIRUS AND METHOD THEREFOR |
| CN105296588A (zh) * | 2015-10-16 | 2016-02-03 | 常州市第一人民医院 | 一种检测肾移植患者在术后感染巨细胞病毒危害程度的方法 |
| US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
| US10611800B2 (en) | 2016-03-11 | 2020-04-07 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| EP3426676A1 (en) | 2016-03-11 | 2019-01-16 | Pfizer Inc | Human cytomegalovirus gb polypeptide |
| US12297266B2 (en) | 2016-04-18 | 2025-05-13 | Celldex Therapeutics, Inc. | Agonistic antibodies that bind human CD40 and uses thereof |
| WO2017184562A1 (en) | 2016-04-20 | 2017-10-26 | Merck Sharp & Dohme Corp. | Cmv neutralizing antigen binding proteins |
| US11185582B2 (en) | 2016-05-09 | 2021-11-30 | Icahn School Of Medicine At Mount Sinai | Broadly neutralizing anti-human cytomegalovirus (HCMV) antibodies and methods of use thereof |
| WO2018005519A2 (en) | 2016-06-27 | 2018-01-04 | The Regents Of The University Of California | Cancer treatment combinations |
| EP3497232A1 (en) | 2016-08-12 | 2019-06-19 | Streck, Inc. | Molecular reference controls |
| CN106519027B (zh) * | 2016-11-11 | 2019-09-17 | 深圳先进技术研究院 | 抗h7n9全人源单克隆抗体5j13及其制法与应用 |
| US11484570B2 (en) | 2017-04-14 | 2022-11-01 | University Of Massachusetts | Targeting cell tropism receptors to inhibit cytomegalovirus infection |
| WO2018193307A1 (en) | 2017-04-19 | 2018-10-25 | Glaxosmithkline Biologicals Sa | Modified cytomegalovirus proteins and stabilized complexes |
| CN107325178A (zh) * | 2017-06-29 | 2017-11-07 | 佛山市南海区普罗圣塔生物科技有限公司 | 一种抗人巨细胞病毒卵黄抗体及其制备方法和应用 |
| CN115119829B (zh) | 2017-10-19 | 2024-07-12 | 斯特雷克股份有限公司 | 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物 |
| WO2019183375A1 (en) * | 2018-03-22 | 2019-09-26 | Eureka Therapeutics, Inc. | Antibody agents specifically recognizing monocarboxylate transporter 4 and uses thereof |
| JP7466459B2 (ja) | 2018-04-17 | 2024-04-12 | セルデックス セラピューティクス インコーポレイテッド | 抗ｃｄ２７および抗ｐｄ－ｌ１抗体ならびに二重特異性構築物 |
| KR102530517B1 (ko) | 2018-07-13 | 2023-05-09 | 알렉터 엘엘씨 | 항-소틸린 항체 및 이들의 사용 방법 |
| CA3116175A1 (en) | 2018-10-17 | 2020-04-23 | Glaxosmithkline Biologicals Sa | Modified cytomegalovirus proteins and stabilized complexes |
| CN109580944A (zh) * | 2018-12-07 | 2019-04-05 | 潍坊医学院 | 一种人巨细胞病毒检测试纸及其制造方法 |
| US11629172B2 (en) | 2018-12-21 | 2023-04-18 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| CN109738631A (zh) * | 2019-01-21 | 2019-05-10 | 潍坊医学院 | 一种人巨细胞病毒IgM抗体检测试纸的制备方法 |
| US20220119502A1 (en) * | 2019-02-28 | 2022-04-21 | Ann And Robert H. Lurie Children's Hospital Of Chicago | Kawasaki disease antibodies identify hepacivirus peptides |
| WO2020208082A1 (en) * | 2019-04-09 | 2020-10-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating cmv related diseases |
| CN118465272B (zh) * | 2019-12-04 | 2025-08-19 | 珠海泰诺麦博制药股份有限公司 | 抗人巨细胞病毒抗体及其用途 |
| US20230174626A1 (en) * | 2020-03-27 | 2023-06-08 | Glaxosmithkline Biologicals Sa | Antibodies |
| US11857622B2 (en) | 2020-06-21 | 2024-01-02 | Pfizer Inc. | Human cytomegalovirus GB polypeptide |
| US20250129140A1 (en) * | 2021-09-03 | 2025-04-24 | Icahn School Of Medicine At Mount Sinai | Anti-hcmv antibodies and antigen-binding fragments thereof |
| CN118580343B (zh) * | 2022-10-21 | 2025-08-19 | 珠海泰诺麦博制药股份有限公司 | 抗人巨细胞病毒抗体及其用途 |
| CN115947869B (zh) * | 2022-11-28 | 2023-12-12 | 广州佰芮慷生物科技有限公司 | 一种靶向人巨细胞病毒的嵌合抗原受体、car-nk细胞及用途 |
Family Cites Families (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3766162A (en) | 1971-08-24 | 1973-10-16 | Hoffmann La Roche | Barbituric acid antigens and antibodies specific therefor |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4294817A (en) * | 1977-11-25 | 1981-10-13 | International Diagnostic Technology, Inc. | Method of fluoro immunoassay |
| US4233402A (en) | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
| US4313927A (en) * | 1979-10-19 | 1982-02-02 | Ames-Yissum Ltd. | Immunoassay method for detecting viral antibodies in whole blood samples |
| US4334016A (en) | 1980-06-19 | 1982-06-08 | The Wistar Institute Of Anatomy And Biology | Human osteogenic sarcoma cell line and use thereof for immunofluorescent antibody test |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| FR2543570B1 (fr) | 1983-03-31 | 1985-08-09 | Pasteur Institut | Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains |
| US4617379A (en) | 1983-06-14 | 1986-10-14 | Miles Laboratories, Inc. | High titer cytomegalovirus immune serum globulin |
| GB8404368D0 (en) | 1984-02-20 | 1984-03-28 | Cogent Ltd | Monoclonal antibodies to human cytomegalovirus |
| US6100064A (en) | 1984-04-06 | 2000-08-08 | Chiron Corporation | Secreted viral proteins useful for vaccines and diagnostics |
| FR2563630B1 (fr) | 1984-04-27 | 1988-02-19 | Pasteur Institut | Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux |
| US4783399A (en) | 1984-05-04 | 1988-11-08 | Scripps Clinic And Research Foundation | Diagnostic system for the detection of cytomegalovirus |
| US4743562A (en) | 1984-08-21 | 1988-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Purified human cytomegalovirus protein |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US4950595A (en) | 1984-09-28 | 1990-08-21 | Teijin Limited | Mouse-human hybridoma which produces antivirus-human antibody, process for preparation thereof, and antivirus-human monoclonal antibody |
| US4808518A (en) * | 1985-02-11 | 1989-02-28 | University Of Tennessee Research Corporation | Recovery of cytomegalovirus antigen and use thereof in an assay |
| US4804627A (en) * | 1985-05-09 | 1989-02-14 | Sloan-Kettering Institute For Cancer Research | Method for cloning lymphoblastoid cells |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| ATE110084T1 (de) | 1985-12-06 | 1994-09-15 | Teijin Ltd | Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung. |
| US6162620A (en) | 1986-03-07 | 2000-12-19 | Cogent Limited | Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor |
| US4831175A (en) | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
| US5126130A (en) | 1986-11-24 | 1992-06-30 | The Childrens Hospital Incorporated | Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
| US5153311A (en) | 1986-11-24 | 1992-10-06 | The Children's Hospital, Incorporated | Immunogenic glycoproteins of human cytomegalovirus gCII |
| LU86752A1 (fr) | 1987-01-30 | 1988-08-23 | Univ Bruxelles | Procede de production d'anticorps monoclonaux humains(igg)anticytomegalovirus et anticorps monoclonaux ainsi obtenus |
| FI884924A7 (fi) | 1987-10-28 | 1989-04-29 | Oncogen | Yhdistelmä-DNA-tekniikalla tuotettuja ihmisimmunoglobuliineja |
| US5180813A (en) * | 1989-03-24 | 1993-01-19 | University Of Iowa Research Foundation | Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| WO1991004277A1 (en) | 1989-09-14 | 1991-04-04 | Children's Biomedical Research Institute | Monoclonal antibodies specific to cytomegalovirus glycoprotein |
| WO1991005876A1 (en) | 1989-10-20 | 1991-05-02 | Children's Biomedical Research Institute | Human cytomegalovirus-specific monoclonal antibody cocktail |
| GB9008223D0 (en) | 1990-04-11 | 1990-06-13 | Royal Free Hosp School Med | Improvements relating to the detection of viruses |
| DE4035174A1 (de) | 1990-11-06 | 1992-05-07 | Biotest Ag | Verfahren zur bestimmung von proteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens |
| US5997878A (en) | 1991-03-07 | 1999-12-07 | Connaught Laboratories | Recombinant poxvirus-cytomegalovirus, compositions and uses |
| JPH053794A (ja) | 1991-06-26 | 1993-01-14 | Green Cross Corp:The | 抗サイトメガロウイルスヒトモノクローナル抗体およびその産生細胞 |
| DE4128684A1 (de) | 1991-08-29 | 1993-03-04 | Behringwerke Ag | Hcmv-spezifische peptide, mittel dazu und ihre verwendung |
| ATE173543T1 (de) | 1992-04-10 | 1998-12-15 | Thomas Totterman | Verfahren zum nachweis einer cmv-infektion |
| SE9201281L (sv) | 1992-04-23 | 1993-10-24 | Bioinvent Int Ab | Nya humana monoklonala antikroppar och förfarande för framställning därav |
| JPH05260961A (ja) | 1992-05-21 | 1993-10-12 | Teijin Ltd | サイトメガロウイルスに対するヒト・モノクローナル抗体を産生するハイブリドーマ |
| GB9221654D0 (en) | 1992-10-15 | 1992-11-25 | Scotgen Ltd | Recombinant human anti-cytomegalovirus antibodies |
| CA2154346A1 (en) | 1993-01-21 | 1994-08-04 | John A. Zaia | Prevention and treatment of cytomegalovirus using aminopeptidase |
| EP0683675A4 (en) | 1993-01-28 | 1997-05-21 | Sandoz Pharmaceuticals Corp | HUMAN MONOCLONAL ANTIBODIES AGAINST CYTOMEGALOVIRUS. |
| US5750106A (en) | 1993-01-28 | 1998-05-12 | Novartis Ag | Human monoclonal antibodies to cytomegalovirus |
| WO1994025490A1 (en) | 1993-04-30 | 1994-11-10 | The Scripps Research Institute | Human monoclonal antibodies to human cytomegalovirus, and methods therefor |
| US5595721A (en) | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| EP0702083A3 (de) | 1994-07-26 | 1997-01-15 | Biotest Ag | Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien |
| US5502652A (en) | 1994-08-24 | 1996-03-26 | Hoggatt; Austin C. | Method and apparatus for measuring heat transfer in small diameter pipes using acoustic signals |
| US5783383A (en) | 1995-05-23 | 1998-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of detecting cytomegalovirus (CMV) |
| US6019980A (en) | 1995-06-07 | 2000-02-01 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
| US5800981A (en) | 1996-02-22 | 1998-09-01 | University Of Limburg | Human cytomegalovirus antigen and its use |
| WO1998002746A1 (en) | 1996-07-12 | 1998-01-22 | Akzo Nobel N.V. | Peptide reagent for the detection of human cytomegalovirus (cmv) |
| EP0964686A4 (en) | 1996-08-14 | 2000-10-18 | Wistar Inst | METHODS AND COMPOSITIONS FOR PREVENTING OR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROTIC DAMAGE |
| US7504493B2 (en) * | 1997-01-23 | 2009-03-17 | The John Hopkins University | Characterization of the yeast transcriptome |
| EP1003841A4 (en) | 1997-01-30 | 2002-04-17 | Cedars Sinai Medical Center | CREATION OF A HSV-8 + LYMPHOMATORY CELL LINE, PRODUCT VIRUS, ANTIBODIES, DIAGNOSTIC METHOD AND KIT FOR DETECTING HSV-8 INFECTION |
| US6183752B1 (en) | 1997-02-05 | 2001-02-06 | Pasteur Merieux Serums Et Vaccins | Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
| US6300104B1 (en) | 1997-06-19 | 2001-10-09 | The Regents Of The University Of California | Secretory immunoglobulin produced by single cells and methods for making and using same |
| BR9815496A (pt) | 1997-07-18 | 2001-12-18 | Connaught Lab | Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório |
| CA2309826A1 (en) | 1997-11-14 | 1999-05-27 | Connaught Laboratories Limited | Alphavirus vectors for paramyxovirus vaccines |
| DE19756214C1 (de) | 1997-12-17 | 1999-02-25 | Biotest Ag | Polypeptide mit Aminosäuresequenzen aus dem N-terminalen Bereich von gp116 und deren Verwendung bei der Diagnostik, Prophylaxe und Therapie |
| ATE226444T1 (de) | 1998-03-12 | 2002-11-15 | Genentech Inc | Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten |
| EP1091763B1 (de) | 1998-06-29 | 2003-09-17 | Wolfgang Bergter | Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern |
| RU2133472C1 (ru) | 1998-09-16 | 1999-07-20 | Унитарное государственное Московское предприятие по производству бактерийных препаратов | Способ диагностики активной стадии цитомегаловирусной инфекции человека |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| MY133346A (en) | 1999-03-01 | 2007-11-30 | Biogen Inc | Kit for radiolabeling ligands with yttrium-90 |
| US7220840B2 (en) | 2000-06-16 | 2007-05-22 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| DE60238309D1 (de) | 2001-02-21 | 2010-12-30 | Wistar Inst | Tomegalovirus genom mit konserviertem wildtyp-charakteristika klinisher isolate enthält |
| ITMI20012160A1 (it) | 2001-10-18 | 2003-04-18 | Edoardo Marchisio | Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test |
| CN1188427C (zh) * | 2001-12-07 | 2005-02-09 | 暨南大学 | 检测hcmv抗体的重组嵌合肽抗原及其产生方法 |
| US6828113B2 (en) | 2002-03-21 | 2004-12-07 | Cornell Research Foundation, Inc. | IgM antibodies to the 70 kDa heat shock protein as a marker for cytomegalovirus infection |
| CN1305905C (zh) | 2002-03-22 | 2007-03-21 | Aprogen株式会社 | 人源化抗体及其制备方法 |
| EP1578980A4 (en) | 2002-04-01 | 2013-01-02 | Agensys Inc | NUCLEIC ACID SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER AND CORRESPONDING PROTEIN HAVING NAME 213P1F11 |
| DE10228103A1 (de) | 2002-06-24 | 2004-01-15 | Bayer Cropscience Ag | Fungizide Wirkstoffkombinationen |
| DE10232322A1 (de) | 2002-07-16 | 2004-07-29 | Hahn, Gabriele, Dr. | Viral kodierte CxC determinieren den Gewebetropismus von HCMV |
| TWI270088B (en) | 2002-11-29 | 2007-01-01 | Furukawa Electric Co Ltd | Insulated wire and resin dispersion |
| RU2239453C2 (ru) | 2002-12-03 | 2004-11-10 | Федеральное государственное унитарное предприятие " Научно-производственное объединение по медицинским иммунобиологическим препаратам " Микроген" | Препарат иммуноглобулина человека против цитомегаловируса и способ его получения |
| CN1445243A (zh) * | 2002-12-13 | 2003-10-01 | 中国疾病控制中心病毒病预防控制所 | 抗人巨细胞病毒人源中和性基因工程Fab抗体 |
| EP1597280B2 (en) | 2003-02-26 | 2016-08-24 | Institute for Research in Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| WO2004076645A2 (en) | 2003-02-27 | 2004-09-10 | University Of Massachusetts | Compositions and methods for cytomegalovirus treatment |
| WO2004078926A2 (en) | 2003-02-28 | 2004-09-16 | Board Of Trustees Operating Michigan State University | Immunologigal markers |
| HUE035082T2 (en) | 2004-06-21 | 2018-05-02 | Squibb & Sons Llc | Interferon alpha receptor 1 antibodies and their use |
| CA2573090A1 (en) | 2004-07-09 | 2006-01-19 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Differences in intestinal gene expression profiles |
| BE1016287A6 (nl) | 2004-07-14 | 2006-07-04 | Picanol Nv | Gaapvormingsonderdeel voor een weefmachine en weefmachine. |
| WO2006056027A1 (en) | 2004-11-29 | 2006-06-01 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus immunotherapy |
| CN105085678B (zh) | 2004-12-21 | 2019-05-07 | 阿斯利康公司 | 血管生成素-2的抗体及其应用 |
| AU2005333155B2 (en) | 2005-03-14 | 2011-11-17 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies against Hendra and Nipah viruses |
| CA2613122C (en) | 2005-06-29 | 2013-01-22 | Compumedics Limited | Sensor assembly with conductive bridge |
| JP5142458B2 (ja) * | 2005-06-30 | 2013-02-13 | キヤノン株式会社 | 標的物質捕捉分子、標的物質捕捉用の素子、これらを用いた標的物質検出用の装置及びキット、並びに、標的物質の検出方法 |
| ATE513034T1 (de) | 2005-12-16 | 2011-07-15 | Ribovax Biotechnologies Sa | Verfahren zur gewinnung immortalisierter antikörpersezernierender zellen |
| JPWO2007094423A1 (ja) | 2006-02-15 | 2009-07-09 | 株式会社イーベック | ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
| CA2652538C (en) | 2006-05-19 | 2016-06-28 | Teva Pharmaceutical Industries, Ltd. | Fusion proteins, uses thereof and processes for producing same |
| CA2654563A1 (en) * | 2006-06-07 | 2007-12-21 | The Trustees Of Princeton University | Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| TW200801513A (en) | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
| RU2448979C2 (ru) * | 2006-12-14 | 2012-04-27 | Ридженерон Фармасьютикалз, Инк. | Антитела человека к дельта-подобному лиганду-4 человека |
| ATE503769T1 (de) * | 2006-12-15 | 2011-04-15 | Ribovax Biotechnologies Sa | Antikörper gegen das humane cytomegalie-virus (hcmv) |
| GB0700133D0 (en) * | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
| US7947274B2 (en) * | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
| US8361473B2 (en) | 2007-03-29 | 2013-01-29 | Technion Research & Development Foundation Ltd. | Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases |
| US20080248042A1 (en) | 2007-04-05 | 2008-10-09 | Irccs Centro Di Riferimento Oncologico Di Aviano, | Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc |
| US20110171233A1 (en) | 2007-08-22 | 2011-07-14 | Ribovax Biotechnologies S.A. | Antibodies Against Human Cytomegalovirus (HCMV) |
| US7763261B2 (en) * | 2007-12-19 | 2010-07-27 | Dcb-Usa Llc | Anti-human cytomegalovirus antibodies |
| WO2010000020A1 (en) | 2008-06-30 | 2010-01-07 | Cathrx Ltd | A catheter |
| CA2730776C (en) | 2008-07-16 | 2018-12-11 | Institute For Research In Biomedicine | Human cytomegalovirus neutralizing antibodies and use thereof |
| CN102143974B (zh) | 2008-07-16 | 2015-03-25 | 生命医学研究学会 | 人巨细胞病毒中和抗体及其用途 |
-
2009
- 2009-07-15 CA CA2730776A patent/CA2730776C/en not_active Expired - Fee Related
- 2009-07-15 SG SG10201608381SA patent/SG10201608381SA/en unknown
- 2009-07-15 SG SG10201706350PA patent/SG10201706350PA/en unknown
- 2009-07-15 PL PL09745098T patent/PL2352759T3/pl unknown
- 2009-07-15 NZ NZ60349909A patent/NZ603499A/en not_active IP Right Cessation
- 2009-07-15 MX MX2013011719A patent/MX343250B/es unknown
- 2009-07-15 JP JP2011518030A patent/JP5422649B2/ja not_active Expired - Fee Related
- 2009-07-15 UA UAA201100565A patent/UA106354C2/ru unknown
- 2009-07-15 DK DK15194590.4T patent/DK3009449T3/en active
- 2009-07-15 AU AU2009272284A patent/AU2009272284C1/en not_active Ceased
- 2009-07-15 BR BRPI0916443A patent/BRPI0916443A2/pt not_active Application Discontinuation
- 2009-07-15 NZ NZ591056A patent/NZ591056A/xx not_active IP Right Cessation
- 2009-07-15 KR KR1020117001825A patent/KR101356350B1/ko not_active Expired - Fee Related
- 2009-07-15 US US12/503,822 patent/US8124093B2/en not_active Expired - Fee Related
- 2009-07-15 EP EP17151249.4A patent/EP3178845A1/en not_active Withdrawn
- 2009-07-15 PE PE2014000662A patent/PE20141432A1/es not_active Application Discontinuation
- 2009-07-15 PE PE2014000665A patent/PE20141434A1/es not_active Application Discontinuation
- 2009-07-15 NZ NZ619953A patent/NZ619953A/en not_active IP Right Cessation
- 2009-07-15 WO PCT/IB2009/006641 patent/WO2010007533A2/en not_active Ceased
- 2009-07-15 PE PE2014000664A patent/PE20141433A1/es not_active Application Discontinuation
- 2009-07-15 EA EA201170205A patent/EA031177B1/ru not_active IP Right Cessation
- 2009-07-15 NZ NZ60349809A patent/NZ603498A/en not_active IP Right Cessation
- 2009-07-15 EP EP09745098.5A patent/EP2352759B1/en active Active
- 2009-07-15 ES ES09745098.5T patent/ES2654543T3/es active Active
- 2009-07-15 CA CA3022196A patent/CA3022196A1/en not_active Abandoned
- 2009-07-15 NZ NZ707788A patent/NZ707788A/en not_active IP Right Cessation
- 2009-07-15 EP EP15194590.4A patent/EP3009449B1/en active Active
- 2009-07-15 ES ES15194590.4T patent/ES2682596T3/es active Active
- 2009-07-15 PE PE2014000171A patent/PE20140882A1/es active IP Right Grant
- 2009-07-15 PT PT97450985T patent/PT2352759T/pt unknown
- 2009-07-15 MX MX2011000543A patent/MX2011000543A/es active IP Right Grant
- 2009-07-15 SG SG2013050927A patent/SG191699A1/en unknown
- 2009-07-15 US US13/003,603 patent/US8603480B2/en not_active Expired - Fee Related
- 2009-07-15 CR CR20160355A patent/CR20160355A/es unknown
- 2009-07-15 PE PE2014000661A patent/PE20141398A1/es not_active Application Discontinuation
- 2009-07-15 CN CN201410204215.5A patent/CN103980363B/zh not_active Expired - Fee Related
- 2009-07-15 CN CN201611150943.8A patent/CN106924729B/zh not_active Expired - Fee Related
- 2009-07-15 MX MX2013011720A patent/MX338067B/es unknown
- 2009-07-15 PT PT151945904T patent/PT3009449T/pt unknown
- 2009-07-15 DK DK09745098.5T patent/DK2352759T3/en active
- 2009-07-15 PL PL15194590T patent/PL3009449T3/pl unknown
- 2009-07-15 PE PE2011000035A patent/PE20110413A1/es active IP Right Grant
- 2009-07-15 CN CN200980129827.XA patent/CN102203133B/zh not_active Expired - Fee Related
- 2009-07-15 PE PE2014000667A patent/PE20141435A1/es not_active Application Discontinuation
- 2009-07-15 MX MX2013011716A patent/MX343490B/es unknown
-
2010
- 2010-12-29 IL IL210356A patent/IL210356A/en active IP Right Grant
-
2011
- 2011-01-14 GT GT201100011CM patent/GT201100011CA/es unknown
- 2011-01-14 GT GT201100011BL patent/GT201100011BA/es unknown
- 2011-01-14 MX MX2013011718A patent/MX340315B/es unknown
- 2011-01-14 GT GT201100011DA patent/GT201100011DA/es unknown
- 2011-01-14 CL CL2011000084A patent/CL2011000084A1/es unknown
- 2011-01-14 HN HN2011000161A patent/HN2011000161A/es unknown
- 2011-01-14 GT GT201100011AK patent/GT201100011AA/es unknown
- 2011-01-17 CU CU2011000009A patent/CU23953B1/es unknown
- 2011-02-11 MA MA33614A patent/MA32561B1/fr unknown
- 2011-02-14 EC ECSP11010826 patent/ECSP11010826A/es unknown
- 2011-02-14 EC ECSP11010827 patent/ECSP11010827A/es unknown
- 2011-02-15 CO CO11017912A patent/CO6351801A2/es active IP Right Grant
- 2011-02-16 CR CR20110091A patent/CR20110091A/es unknown
- 2011-12-28 US US13/338,934 patent/US8287870B2/en not_active Expired - Fee Related
- 2011-12-28 US US13/338,905 patent/US8298539B2/en not_active Expired - Fee Related
-
2012
- 2012-09-10 US US13/608,726 patent/US8435524B2/en not_active Expired - Fee Related
-
2013
- 2013-04-16 US US13/863,782 patent/US8765132B2/en active Active
- 2013-10-22 JP JP2013218791A patent/JP5807050B2/ja not_active Expired - Fee Related
- 2013-12-04 US US14/096,283 patent/US9221897B2/en not_active Expired - Fee Related
- 2013-12-23 US US14/138,531 patent/US9127049B2/en not_active Expired - Fee Related
-
2014
- 2014-05-16 CL CL2014001293A patent/CL2014001293A1/es unknown
- 2014-05-29 IL IL232863A patent/IL232863A/en active IP Right Grant
- 2014-05-29 IL IL232864A patent/IL232864A/en active IP Right Grant
- 2014-05-29 IL IL232861A patent/IL232861A/en active IP Right Grant
- 2014-05-29 IL IL232865A patent/IL232865A/en active IP Right Grant
- 2014-05-29 IL IL232862A patent/IL232862A/en active IP Right Grant
-
2015
- 2015-04-08 PH PH12015500782A patent/PH12015500782A1/en unknown
- 2015-04-14 JP JP2015082325A patent/JP6062477B2/ja not_active Expired - Fee Related
- 2015-04-22 IL IL238421A patent/IL238421A/en active IP Right Grant
- 2015-07-31 US US14/815,162 patent/US9249213B2/en not_active Expired - Fee Related
- 2015-11-23 US US14/949,161 patent/US9365636B1/en not_active Expired - Fee Related
- 2015-12-17 US US14/973,409 patent/US9371372B2/en not_active Expired - Fee Related
-
2016
- 2016-01-15 ZA ZA2016/00335A patent/ZA201600335B/en unknown
- 2016-05-13 US US15/154,178 patent/US9527902B2/en not_active Expired - Fee Related
- 2016-05-17 US US15/156,786 patent/US9491906B2/en not_active Expired - Fee Related
- 2016-06-01 CL CL2016001340A patent/CL2016001340A1/es unknown
- 2016-10-04 US US15/284,799 patent/US9725502B2/en not_active Expired - Fee Related
- 2016-11-22 US US15/358,868 patent/US9796772B2/en not_active Expired - Fee Related
- 2016-11-22 US US15/358,845 patent/US9796771B2/en not_active Expired - Fee Related
- 2016-12-14 JP JP2016241815A patent/JP6345753B2/ja not_active Expired - Fee Related
-
2017
- 2017-06-29 US US15/637,513 patent/US9803000B1/en not_active Expired - Fee Related
- 2017-09-27 US US15/716,818 patent/US10040845B2/en active Active
-
2018
- 2018-05-23 JP JP2018098457A patent/JP6703037B2/ja not_active Expired - Fee Related
- 2018-07-02 US US16/025,296 patent/US10414817B2/en not_active Expired - Fee Related
-
2019
- 2019-07-31 US US16/527,836 patent/US10889632B2/en not_active Expired - Fee Related
-
2020
- 2020-09-03 US US17/011,934 patent/US20210087257A1/en not_active Abandoned